These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 21788507)
1. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Svensson KJ; Kucharzewska P; Christianson HC; Sköld S; Löfstedt T; Johansson MC; Mörgelin M; Bengzon J; Ruf W; Belting M Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13147-52. PubMed ID: 21788507 [TBL] [Abstract][Full Text] [Related]
2. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Kucharzewska P; Christianson HC; Welch JE; Svensson KJ; Fredlund E; Ringnér M; Mörgelin M; Bourseau-Guilmain E; Bengzon J; Belting M Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7312-7. PubMed ID: 23589885 [TBL] [Abstract][Full Text] [Related]
3. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687 [TBL] [Abstract][Full Text] [Related]
4. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells. Rothmeier AS; Versteeg HH; Ruf W J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873 [TBL] [Abstract][Full Text] [Related]
5. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization. Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924 [TBL] [Abstract][Full Text] [Related]
6. A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGF. Sato S; Drake AW; Tsuji I; Fan J PLoS One; 2012; 7(12):e51964. PubMed ID: 23251664 [TBL] [Abstract][Full Text] [Related]
7. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer. Chanakira A; Westmark PR; Ong IM; Sheehan JP Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395 [TBL] [Abstract][Full Text] [Related]
8. Human airway trypsin-like protease induces amphiregulin release through a mechanism involving protease-activated receptor-2-mediated ERK activation and TNF alpha-converting enzyme activity in airway epithelial cells. Chokki M; Eguchi H; Hamamura I; Mitsuhashi H; Kamimura T FEBS J; 2005 Dec; 272(24):6387-99. PubMed ID: 16336275 [TBL] [Abstract][Full Text] [Related]
9. Tissue factor in cancer progression and angiogenesis. Ruf W; Yokota N; Schaffner F Thromb Res; 2010 Apr; 125 Suppl 2(0 2):S36-8. PubMed ID: 20434002 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells. Gessler F; Voss V; Dützmann S; Seifert V; Gerlach R; Kögel D Neuroscience; 2010 Feb; 165(4):1312-22. PubMed ID: 19958818 [TBL] [Abstract][Full Text] [Related]
11. PAR2-SMAD3 in microvascular endothelial cells is indispensable for vascular stability via tissue factor signaling. Arderiu G; Espinosa S; Peña E; Aledo R; Badimon L J Mol Cell Biol; 2016 Jun; 8(3):255-70. PubMed ID: 26658897 [TBL] [Abstract][Full Text] [Related]
12. Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer. Rydén L; Grabau D; Schaffner F; Jönsson PE; Ruf W; Belting M Int J Cancer; 2010 May; 126(10):2330-40. PubMed ID: 19795460 [TBL] [Abstract][Full Text] [Related]